Fibrolamellar carcinoma presenting as a pancreatic mass: Case report and review of the literature

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 5, 2009, Pages 370-372

  Thirabanjasak, Duangpen ^a   Sosothikul, Darintr ^a   Mahayosnond, Atchara ^a   Thorner, Paul S ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEPATOMEGALY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; METASTASIS; METASTATIC FIBROLAMELLAR CARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR BIOPSY; DIFFERENTIAL DIAGNOSIS; LIVER TUMOR; REVIEW;

CARCINOMA, HEPATOCELLULAR; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER NEOPLASMS; MALE; PANCREATIC NEOPLASMS;

EID: 66149126985     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181984f7f     Document Type: Article

References (16)

1. Czauderna P, Mackinlay G, Perilongo G, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol. 2002;20:2798-2804.
2. Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980;46:372-379.
3. Hodgson HJ. Fibrolamellar cancer of the liver. J Hepatol. 1987;5:241-247.
4. Kakar S, Burgart LJ, Batts KP, et al. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol. 2005;18:1417-1423.
5. Haas JE, Muczynski KA, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer. 1989;64:1082-1095.
6. Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 2003;97:2006-2012.
7. Soreide O, Czerniak A, Bradpiece H, et al. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg. 1986;151:518-523.
8. Epstein BE, Pajak TF, Haulk TL, et al. Metastatic non-resectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol. 1999;22:22-28.
9. Hiramatsu K, Okamoto K, Uesaka K, et al. Surgical management for lymph node recurrence of resected fibrolamellar hepatocellular carcinoma: a case report. Hepatogastroenterology. 1999;46:1160-1163.
10. Ferrell L. Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems. Mod Pathol. 2000;13:679-704.
11. Teitelbaum DH, Tuttle S, Carey LC, et al. Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Ann Surg. 1985;202:36-41.
12. Berman MA, Burnham JA, Sheahan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol. 1988; 19:784-794.
13. Dusenbery D, Carr BI. Fine needle aspiration diagnosis of hepatocellular carcinoma in metastatic sites. Acta Cytol. 1996; 40:443-449.
14. Lowe CJ Jr, Riepe SP, Wood WC. Hepatocellular carcinoma presenting as a pancreatic head mass: report of an unusual case. Am J Clin Oncol. 1997;20:509-510.
15. Texler ML, Pierides J, Maddern GJ. Case report: a hepatocellular carcinoma metastasis in the distal pancreas. J Gastroenterol Hepatol. 1998;13:467-470.
16. Ichikawa T, Federle MP, Grazioli L, et al. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology. 1999;213:352-361.